Skip to main content
Explore URMC

Alexis A. Lizarraga, M.D., M.S.


Showing all 16 journal articles & 3 books available

Journal Articles

Jakimovski D, Zakalik K, Awan S, Kavak KS, Pennington P, Hojnacki D, Kolb C, Lizarraga AA, Eckert SP, Sarrosa R, Vineetha K, Edwards K, Weinstock-Guttman B. "COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections" . Vaccines. 2022; 10(5):695.

Vargas NT, Chapman CL, Reed EL, Lizarraga A, Fisher NM, Davis SL, Schlader ZJ. "Voluntary Cooling during Exercise Is Augmented in People with Multiple Sclerosis Who Experience Heat Sensitivity." Medicine and science in sports and exercise.. 2021 Nov 1; 53(11):2405-2418.

Lizarraga AA, Rammohan KW, Weinstock-Guttman B, Sharma K. "Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients." Multiple sclerosis and related disorders.. 2021 Nov; 56:103254. Epub 2021 Sep 04.

Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ, . "Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD." Annals of neurology.. 2021 Jun; 89(6):1088-1098. Epub 2021 Feb 27.

Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ, . "Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study." Neurology.. 2021 Jan 26; 96(4):e491-e500. Epub 2020 Dec 02.

Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. "Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis." Multiple sclerosis and related disorders.. 2021 Jan; 47:102653. Epub 2020 Dec 04.

Jakimovski D, Dujmic D, Hagemeier J, Ramasamy DP, Bergsland N, Dwyer MG, Eckert S, Kolb C, Lizarraga A, Hojnacki D, Weinstock-Guttman B, Zivadinov R. "Late onset multiple sclerosis is associated with more severe ventricle expansion." Multiple sclerosis and related disorders.. 2020 Nov; 46:102588. Epub 2020 Oct 17.

Lizarraga AA, Weinstock-Guttman B. "Multiple sclerosis in 2019: predicting progression." The Lancet. Neurology.. 2020 Jan; 19(1):12-14.

Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. "Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis." Radiology.. 2019 Nov; 293(2):424-433. Epub 2019 Sep 24.

Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B. "Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study." Journal of clinical medicine.. 2019 Mar 12; 8(3)Epub 2019 Mar 12.

Abdollahpour I, Lizarraga AA, Nedjat S, Mansournia MA, Weinstock-Guttman B. "Medical History and Multiple Sclerosis: A Population-Based Incident Case-Control Study." Neuroepidemiology.. 2019 52(1-2):55-62. Epub 2018 Nov 26.

Ozel O, Vaughn CB, Eckert SP, Jakimovski D, Lizarraga AA, Weinstock-Guttman B. "Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives." Patient related outcome measures.. 2019 10:373-384. Epub 2019 Dec 11.

Lizarraga AA, Cochrane TI, Berkowitz AL. "Improvement of distal acquired demyelinating symmetric (DADS) neuropathy after exposure to factor Xa inhibitor." Journal of the neurological sciences.. 2018 May 15; 388:146-149. Epub 2018 Mar 10.

Lizarraga AA, Lizarraga KJ, Hoffman JE, Ascherman DP, Shebert RT, Verma A. "Severe mononeuritis multiplex after rituximab in IgM-? monoclonal gammopathy." Muscle & nerve.. 2018 Apr; 57(4):E115-E118. Epub 2017 Dec 01.

Lizarraga AA, Lizarraga KJ, Benatar M. "Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome." Seminars in neurology.. 2016 Dec; 36(6):615-624. Epub 2016 Dec 01.

Economos A, Wright CB, Moon YP, Rundek T, Rabbani L, Paik MC, Sacco RL, Elkind MS. "Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study." Neuroepidemiology.. 2013 40(4):253-9. Epub 2013 Jan 24.

Books & Chapters

Chapter Title: Multiple Sclerosis: clinical features, immunopathogenesis, and clinical management
Book Title: Inflammatory disorders of the nervous system, 2nd Edition
Author List: Lizarraga AA, Sheremata WA.
Published By: Humana Press2017

Chapter Title: Neuromuscular Junction Disorders
Book Title: Pocket Neurology, 2nd Edition
Author List: Lizarraga A & Berry J
Published By: Lippincott, Williams & Wilkins2016

Chapter Title: Vascular dementia and vascular cognitive impairment
Book Title: Stroke: Pathophysiology, Diagnosis, and Management, 6th Edition
Author List: Seshadri S, Economos A, Wright CB
Published By: Elsevier Health Sciences2015